Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF3 | hg38_v1_chr19_-_49665603_49665617 | 0.39 | 2.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_73982019 Show fit | 10.88 |
ENST00000296029.4
|
platelet factor 4 |
|
chr19_+_18173804 Show fit | 8.49 |
ENST00000407280.4
|
IFI30 lysosomal thiol reductase |
|
chr17_-_35880350 Show fit | 8.48 |
ENST00000605140.6
ENST00000651122.1 ENST00000603197.6 |
C-C motif chemokine ligand 5 |
|
chr2_+_162318884 Show fit | 7.73 |
ENST00000446271.5
ENST00000429691.6 |
grancalcin |
|
chr12_+_112978562 Show fit | 7.18 |
ENST00000680122.1
|
2'-5'-oligoadenylate synthetase 2 |
|
chr2_+_218260991 Show fit | 6.74 |
ENST00000522678.5
ENST00000519574.2 ENST00000521462.1 |
G protein-coupled bile acid receptor 1 |
|
chr3_-_36908503 Show fit | 6.49 |
ENST00000463764.2
|
tetratricopeptide repeat and ankyrin repeat containing 1 |
|
chr6_-_132763424 Show fit | 6.45 |
ENST00000532012.1
ENST00000525270.5 ENST00000530536.5 ENST00000524919.5 |
vanin 2 |
|
chr5_-_43040311 Show fit | 5.80 |
ENST00000616064.2
|
annexin A2 receptor |
|
chr12_+_112978424 Show fit | 5.43 |
ENST00000680685.1
ENST00000620097.2 |
2'-5'-oligoadenylate synthetase 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 32.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 16.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 15.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.6 | 10.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.9 | 10.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
3.2 | 9.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
3.2 | 9.6 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.6 | 9.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 8.6 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
2.1 | 8.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 37.8 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 11.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
3.6 | 10.9 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) other organism cytoplasm(GO:0097679) |
1.4 | 9.7 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 8.8 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 7.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 5.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 5.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.2 | 4.7 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.1 | 4.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 39.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 12.4 | GO:0004386 | helicase activity(GO:0004386) |
2.2 | 10.9 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.2 | 9.7 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 9.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 8.7 | GO:0070403 | NAD+ binding(GO:0070403) |
2.9 | 8.6 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
1.7 | 8.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 8.5 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 7.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 15.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 14.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 10.9 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 8.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 4.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 3.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 2.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 2.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 64.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 12.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.6 | 10.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 8.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 8.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 8.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 7.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 7.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 6.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 5.7 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |